Mitsubishi UFJ Asset Management (UK)’s Immunome IMNM Stock Holding History

Mitsubishi UFJ Asset Management (UK)’s Portfolio IMNM Stock Details IMNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$175K	Buy	+8,000	New	+$178K	0.09%	90

Other funds holding IMNM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Mitsubishi UFJ Asset Management (UK)'s IMNM Position: Q1 2026 in Review

Mitsubishi UFJ Asset Management (UK) opened a new position in Immunome (IMNM) in Q1 2026: 8,000 shares worth $175K. The stake represents 0.09% of the portfolio and ranks #90 among its holdings.

200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

Mitsubishi UFJ Asset Management (UK) held 8,000 shares of Immunome worth $175K as of Q1 2026.
Immunome was a new Mitsubishi UFJ Asset Management (UK) position in Q1 2026.
Immunome made up 0.09% of Mitsubishi UFJ Asset Management (UK)'s portfolio in Q1 2026, its #90 holding.
200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Mitsubishi UFJ Asset Management (UK)'s 13F filing for Q1 2026, filed 8 May 2026.